Vaccinex, inc. (VCNX)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-29,945

-31,863

-33,986

-32,943

-30,723

-29,518

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

-

-

-

-

-

-

0

0

0

Depreciation

0

-

-

-

0

-

-

-

-

Amortization of debt discount

-

-

-

-

-

308

0

0

0

Net amortization of premiums and discounts on marketable securities

-

44

0

0

0

-

-

-

-

Stock-based compensation

591

447

355

262

201

177

0

0

0

Change in fair value of derivative liabilities

-

-

-

-

-

369

0

0

0

Loss on extinguishment of related party convertible promissory note

-

-

-

-

-

-2,379

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

141

260

685

519

548

522

0

0

0

Prepaid expenses and other current assets

-116

-725

-912

-421

90

384

0

0

0

Accounts payable

605

725

119

2,533

190

421

0

0

0

Accrued expenses

-1,237

-694

735

876

2,254

2,407

0

0

0

Deferred revenue

-

-

-

-

-

-298

0

0

0

Net cash used in operating activities

-29,749

-30,715

-32,469

-29,199

-28,587

-25,276

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Sales of marketable securities

-

14,151

0

0

0

-

-

-

-

Purchase of property and equipment

0

-

-

-

-

235

0

0

0

Net cash (used in) provided by investing activities

2,019

14,073

15,990

-97

-2,394

-14,241

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from private offering of common stock

0

-

-

-

-

-

-

-

-

Payments of initial public offering costs

-

-

-

-

-

2,675

0

0

0

Proceeds from exercise of stock options

0

-

-

-

-

-

-

-

-

Repayment of convertible promissory note, related party

-

-

-

-

-

5,500

0

0

0

Proceeds from capital contribution

-

-

-

-

-

12,000

0

0

0

Net cash provided by financing activities

0

-

-

-

-

40,955

0

0

0

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

0

-

-

-

0

-

-

-

-

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for interest

-

-

-

-

-

-

-

-

0

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

-

-

-

-

-

-

-

0

0

SUPPLEMENTAL DISCLOSURES OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Purchase of property and equipment in accounts payable

0

-

-

-

-

-

-

-

0

Deferred offering costs in prepaid assets and accrued liabilities

0

-

-

-

-

-

-

-

-

Deferred offering costs in prepaid assets and accounts payable

0

-

-

-

-

-

-

0

0

Deferred offering costs reclassed from prepaid expenses and other current assets

-

-

-

-

-

-

-

-

0